{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T04:11:42Z","timestamp":1792987902160,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.ando.2016.03.002","type":"journal-article","created":{"date-parts":[[2016,7,2]],"date-time":"2016-07-02T22:46:15Z","timestamp":1467499575000},"page":"615-619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Hyperparathyroidism complicating CYP 24A1 mutations"],"prefix":"10.1016","volume":"77","author":[{"given":"Camille","family":"Loyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Molin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Fran\u00e7oise","family":"Odou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Huglo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Lion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Porchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Carnaille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Pattou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Kottler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Vantyghem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2016.03.002_bib0005","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJMoa1103864","article-title":"Mutations in CYP24A1 and idiopathic infantile hypercalcemia","volume":"365","author":"Schlingmann","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2016.03.002_bib0010","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/ndt\/gft460","article-title":"Chronic hypercalcaemia from inactivating mutations of vitamin D 24-hydroxylase (CYP24A1): implications for mineral metabolism changes in chronic renal failure","volume":"29","author":"Colussi","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ando.2016.03.002_bib0015","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/ckj\/sft008","article-title":"Medullary nephrocalcinosis in an adult patient with idiopathic infantile hypercalcaemia and a novel CYP24A1 mutation","volume":"6","author":"Meusburger","year":"2013","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ando.2016.03.002_bib0020","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.juro.2013.02.3188","article-title":"Loss-of-function mutations of CYP24A1, the vitamin D 24-hydroxylase gene, cause long-standing hypercalciuric nephrolithiasis and nephrocalcinosis","volume":"190","author":"Dinour","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.ando.2016.03.002_bib0025","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2215\/CJN.05360512","article-title":"1,25-(OH)2D-24-hydroxylase (CYP24A1) deficiency as a cause of nephrolithiasis","volume":"8","author":"Nesterova","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ando.2016.03.002_bib0030","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1681\/ASN.2014101025","article-title":"Autosomal-recessive mutations in SLC34A1 encoding sodium-phosphate cotransporter 2a cause idiopathic infantile hypercalcemia","volume":"27","author":"Schlingmann","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ando.2016.03.002_bib0035","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1210\/jc.2013-3802","article-title":"A lifetime of hypercalcemia and hypercalciuria, finally explained","volume":"99","author":"Jacobs","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.03.002_bib0040","doi-asserted-by":"crossref","first-page":"E1343","DOI":"10.1210\/jc.2014-4387","article-title":"CYP24A1 Mutations in a cohort of hypercalcemic patients: evidence for a recessive trait","volume":"100","author":"Molin","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.03.002_bib0045","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1210\/jc.2015-1973","article-title":"Maternal hypercalcemia due to failure of 1,25-Dihydroxyvitamin-D3 catabolism in a patient with CYP24A1 mutations","volume":"100","author":"Shah","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.03.002_bib0050","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1053\/j.ajkd.2014.06.037","article-title":"Kidney function and influence of sunlight exposure in patients with impaired 24-hydroxylation of vitamin D due to CYP24A1 mutations","volume":"65","author":"Figueres","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ando.2016.03.002_bib0055","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/ckj\/sfv058","article-title":"The hypercalcaemia of CYP24A1 inactivation: new ways to improve diagnosis and treatment","volume":"8","author":"Dusso","year":"2015","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ando.2016.03.002_bib0060","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1210\/jc.2013-4388","article-title":"Clinical utility of simultaneous quantitation of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D by L\u2013MS\/MS involving derivatization with DMEQ-TAD","volume":"99","author":"Kaufmann","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.03.002_bib0065","doi-asserted-by":"crossref","first-page":"e1701","DOI":"10.1097\/MD.0000000000001701","volume":"94","author":"Michaud","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ando.2016.03.002_bib0070","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s40618-014-0165-7","article-title":"Vitamin D-neutralizing CYP24A1 expression, oncogenic mutation states and histological findings of human papillary thyroid cancer","volume":"38","author":"Balla","year":"2015","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ando.2016.03.002_bib0075","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/cen.12396","article-title":"Increased CYP24A1 expression is associated with BRAFV600E mutation and advanced stages in papillary thyroid carcinoma","volume":"81","author":"Zou","year":"2014","journal-title":"Clin Endocrinol"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426616300695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426616300695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:49:36Z","timestamp":1757717376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426616300695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0003426616300695"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2016.03.002","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperparathyroidism complicating CYP 24A1 mutations","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2016.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}